Literature DB >> 34029337

Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.

Michel Goldman1, Cédric Hermans2.   

Abstract

Michel Goldman and Cédric Hermans discuss thrombotic mechanisms in COVID-19 and rare adverse reactions to SARS-CoV-2 vaccinations.

Entities:  

Year:  2021        PMID: 34029337     DOI: 10.1371/journal.pmed.1003648

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.069


  13 in total

1.  Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.

Authors:  Pedro M Folegatti; Daniel Jenkin; Susan Morris; Sarah Gilbert; Denny Kim; James S Robertson; Emily R Smith; Emalee Martin; Marc Gurwith; Robert T Chen
Journal:  Vaccine       Date:  2022-06-14       Impact factor: 4.169

2.  Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis.

Authors:  Noppacharn Uaprasert; Nuanrat Tangcheewinsirikul; Ponlapat Rojnuckarin; Rushad Patell; Jeffrey I Zwicker; Thita Chiasakul
Journal:  Blood Adv       Date:  2021-11-09

Review 3.  Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).

Authors:  Junaid Kashir; Ayesha Rahman Ambia; Areez Shafqat; Muhammad Raihan Sajid; Khaled AlKattan; Ahmed Yaqinuddin
Journal:  J Leukoc Biol       Date:  2021-09-01       Impact factor: 6.011

Review 4.  Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.

Authors:  Emmanuel J Favaloro; Leonardo Pasalic; Giuseppe Lippi
Journal:  Antibodies (Basel)       Date:  2022-01-21

5.  Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes.

Authors:  Vasiliki E Georgakopoulou; Panagiotis Lembessis; Charalampos Skarlis; Aikaterini Gkoufa; Nikolaos V Sipsas; Clio P Mavragani
Journal:  Front Med (Lausanne)       Date:  2022-03-17

Review 6.  Hematopoietic responses to SARS-CoV-2 infection.

Authors:  Shokrollah Elahi
Journal:  Cell Mol Life Sci       Date:  2022-03-13       Impact factor: 9.207

7.  Subarachnoid hemorrhage: management considerations for COVID-19.

Authors:  Eric J Panther; Brandon Lucke-Wold
Journal:  Explor Neuroprotective Ther       Date:  2022-03-02

Review 8.  Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic.

Authors:  Toshiaki Iba; Jerrold H Levy; Marcel Levi
Journal:  Thromb Haemost       Date:  2021-09-13       Impact factor: 6.681

9.  COVID-19 vaccines: what do we know so far?

Authors:  Paraminder Dhillon; Daniel Altmann; Victoria Male
Journal:  FEBS J       Date:  2021-07-19       Impact factor: 5.622

Review 10.  Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.